CoChat

Mast cell stabilizer ketotifen reduces hyperalgesia in a rodent model of surgically induced endometriosis

Open access
Zhu, Tian-hong, Zou, Gen, Ding, Shao-jie, Li, Tian-tian, Zhu, Li-bo, Wang, Jian-zhang, Yao, Yong-xing, Zhang, Xin-mei · 2019 · Journal of Pain Research

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index; none of the 39 sources its claims cite is checked for support yet.

Abstract

Purpose: This study aimed to investigate the effect of oral treatment with ketotifen, a mast cell (MC) stabilizer, in a rat model of surgically induced endometriosis. Methods: At 14 days after Sprague–Dawley rats had surgery, they were treated with ketotifen (1 or 10 mg/kg/day). Pain behaviors were evaluated 3 days prior to surgery and then at 7, 14, 21, and 28 days after surgery. At day 28, rats were sacrificed and all samples were then processed for biochemical studies. Results: We found that ketotifen-treated rats showed significantly shorter duration of hyperalgesia ( p <0.05); smaller cyst diameter ( p <0.05) and lower histopathologic score ( p <0.001); significantly lower MC number and degranulation ( p <0.001), blood vessel number ( p <0.001), lower expression levels of nerve growth factor ( p <0.001), cyclooxygenase-2 ( p <0.001), intercellular cell adhesion molecule-1 ( p <0.001), and vascular endothelial growth factor ( p <0.05) in cysts, and nerve growth factor ( p <0.001) and transient receptor potential cation channel, subfamily V, member 1 ( p <0.001) in dorsal root ganglia; and lower histamine ( p <0.05) and tumor necrosis factor-alpha ( p <0.05) concentrations in serum compared with placebo-treated animal subjects. Conclusion: Oral treatment with ketotifen significantly suppressed the development of hyperalgesia, probably by modulating MC activity in cysts, thereby reducing peripheral sensitization due to noxious signals from endometriotic lesions. Our results suggest that ketotifen may inhibit the development of endometriotic lesions and hyperalgesia in rats. Keywords: endometriosis, ketotifen, rat, mast cells, hyperalgesia

Overview

CoChat Summary

TL;DR

In a surgically induced rat model of endometriosis, oral ketotifen reduced hyperalgesia and was associated with lower mast cell activity, smaller cysts, and reduced expression of several inflammatory/algogenic markers. The paper concludes ketotifen may be a mechanism-based candidate for endometriosis-associated pain, but notes that further experimental and clinical studies are needed.

Key findings

  • Rats with experimental endometriosis had significantly lower mechanical thresholds and paw withdrawal latencies by day 14 after surgery than sham-operated rats; after 14 days of treatment, ketotifen (1 or 10 mg/kg/day) produced significantly higher thresholds than vehicle.
  • Ketotifen reduced mast cell number and degranulation in endometriotic cysts: the control group had higher mast cell counts and degranulation rates than both ketotifen groups, with p < 0.001; there was no significant difference between 1 and 10 mg/kg.
  • Ketotifen suppressed lesion pathology: cyst epithelium showed atrophy/regression, vessel number was lower than in controls (p < 0.001), and cyst size was smaller in both ketotifen groups (p < 0.05); no significant low-vs-high dose difference was seen for vessel number or cyst size.
  • Ketotifen downregulated marker expression in cysts and DRG, including NGF, COX-2, ICAM-1, VEGF, NGF, and TRPV1; serum histamine and TNF-α were also reduced versus vehicle (p < 0.05), with some dose differences for NGF/ICAM-1 and TRPV1 but not for COX-2, VEGF, histamine, or TNF-α.

Methods

  • Experimental design: female Sprague–Dawley rats with surgically induced endometriosis via autologous uterine horn transplantation were randomized to sham operation (n = 6), vehicle control (n = 6), ketotifen 1 mg/kg/day (n = 6), or ketotifen 10 mg/kg/day (n = 6); treatment was given by oral gavage from day 14 to day 28 after surgery.
  • Outcomes measured: mechanical hyperalgesia (von Frey thresholds), thermal hyperalgesia (paw withdrawal latency), histology (endometriosis score, vessel number, cyst size), mast cell density/degranulation, IHC for NGF, COX-2, ICAM-1, VEGF, and DRG NGF/TRPV1, plus serum histamine and TNF-α by ELISA.
  • Main analysis: data were summarized as mean ± SEM and compared by one-way ANOVA; Pearson correlation was used to relate mast cell number to pain behavior.

Limitations

  • The paper explicitly states that “no clear dose–effect relationship was observed” and that further experimental and clinical studies will be needed for confirmation.
  • Evident from the text: this is a small animal study with 6 rats per group, so generalizability to humans is limited.
  • Evident from the text: treatment began 14 days after surgery, so the study addresses therapeutic effects after lesion establishment rather than prevention.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.2147/jpr.s195909

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Ketotifen treatment suppressed the development of hyperalgesia in rats with experimentally induced endometriosis. Mechanical nociceptive testing (A). Thermal nociceptive testing (B). Each group comprised six rats. *p<0.05. Abbreviation: NS, not significant.
Figure 1 Ketotifen treatment suppressed the development of hyperalgesia in rats with experimentally induced endometriosis. Mechanical nociceptive testing (A). Thermal nociceptive testing (B). Each group comprised six rats. *p<0.05. Abbreviation: NS, not significant.CC BY-NC · PubMed Central
Figure 2 Ketotifen treatment decreased the number of MCs and inhibited its activity of degranulation. MCs were mainly distributed in the stroma (A–C). MCs were noted around blood vessels (D–F). Ketotifen (1/mg/kg/day) (A and D). Ketotifen (10/mg/kg/day) (B and E). Control (CMC-Na) (C and F). The degranulated MCs, characterized by uneven staining and incomplete cell membranes, were indicated by the white arrows, whereas the granulated MCs, with uniform color and intact cell membranes, were indicated by the black arrow. Scale bars=50 μm.
Figure 2 Ketotifen treatment decreased the number of MCs and inhibited its activity of degranulation. MCs were mainly distributed in the stroma (A–C). MCs were noted around blood vessels (D–F). Ketotifen (1/mg/kg/day) (A and D). Ketotifen (10/mg/kg/day) (B and E). Control (CMC-Na) (C and F). The degranulated MCs, characterized by uneven staining and incomplete cell membranes, were indicated by the white arrows, whereas the granulated MCs, with uniform color and intact cell membranes, were indicated by the black arrow. Scale bars=50 μm.CC BY-NC · PubMed Central
Figure 3 Ketotifen treatment suppressed the development of endometriotic lesions in rats subjected to experimentally induced endometriosis. Histology of tissues (A–C). Density of blood vessels (D–F). Histopathologic scores of different treatments in endometriosis-afflicted rats (G). Density of blood vessels Number of blood vessels in different treatments in endometriosis-afflicted rats (H). Changes in cyst volume before and after different treatments in endometriosis-afflicted rats (I). Scale bars=50 μm. *p<0.05; ***p<0.001.
Figure 3 Ketotifen treatment suppressed the development of endometriotic lesions in rats subjected to experimentally induced endometriosis. Histology of tissues (A–C). Density of blood vessels (D–F). Histopathologic scores of different treatments in endometriosis-afflicted rats (G). Density of blood vessels Number of blood vessels in different treatments in endometriosis-afflicted rats (H). Changes in cyst volume before and after different treatments in endometriosis-afflicted rats (I). Scale bars=50 μm. *p<0.05; ***p<0.001.CC BY-NC · PubMed Central
Figure 4 Ketotifen treatment downregulated the expression of NGF, Cox-2, ICAM-1, and VEGF in endometriotic cysts. Scale bars=50 μm.
Figure 4 Ketotifen treatment downregulated the expression of NGF, Cox-2, ICAM-1, and VEGF in endometriotic cysts. Scale bars=50 μm.CC BY-NC · PubMed Central
Figure 5 Ketotifen treatment downregulated the expression of NGF and TRPV1 in dorsal root ganglia (DRG). Scale bars=50 μm.
Figure 5 Ketotifen treatment downregulated the expression of NGF and TRPV1 in dorsal root ganglia (DRG). Scale bars=50 μm.CC BY-NC · PubMed Central
Figure 6 Ketotifen treatment reduced histamine and TNF-α concentrations in serum. Histamine concentration in serum (A). TNF-α concentration in serum (B). *P<0.05.
Figure 6 Ketotifen treatment reduced histamine and TNF-α concentrations in serum. Histamine concentration in serum (A). TNF-α concentration in serum (B). *P<0.05.CC BY-NC · PubMed Central
Figure 7 Correlations between the number of MC and hyperalgesia. Correlation of number of MC and mechanical threshold (A) and thermal latency (B); Correlation of number of degranulated MC and mechanical threshold (C) and thermal latency (D). The Pearson coefficient of correlation and the significance of this correlation are shown in the lower right corner.
Figure 7 Correlations between the number of MC and hyperalgesia. Correlation of number of MC and mechanical threshold (A) and thermal latency (B); Correlation of number of degranulated MC and mechanical threshold (C) and thermal latency (D). The Pearson coefficient of correlation and the significance of this correlation are shown in the lower right corner.CC BY-NC · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 20 Not checked · 55 Own results and interpretations

37 more claims

Create a free account to see all 75 claims and to verify the 39 references still open.

See all claims — free account
  • Probably not a substantial claim. 23
  • It may state two separate claims as one. 12

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 41 references

Cited by

See all 43

Metadata

Authors
Zhu, T.-H., Zou, G., Ding, S.-J., Li, T.-T., Zhu, L.-B., Wang, J.-Z., Yao, Y.-X., & Zhang, X.-M.
Affiliations
  • Women's Hospital, School of Medicine, Zhejiang University (CN)
  • First Affiliated Hospital Zhejiang University (CN)
Venue
Journal of Pain Research
Published
2019-04
Volume
Volume 12
Pages
1359-1369
ISSN
1178-7090 (ISSN-L)
OpenAlex
W2941459715
Cited by
43
References
41
Citations by year
2026: 3 · 2025: 14 · 2024: 3 · 2023: 10 · 2022: 5 · 2021: 5 · 2020: 3
FWCI
3.11
Type
journal article
Language
en
Open access
Locations
  • Journal of Pain Research (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
National Natural Science Foundation of China (81671429, 2017YFC1001202, 81471433, 81471127)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Plant and fungal interactions
Keywords
ketotifen, mast cell stabilizers, endometriosis, hyperalgesia, surgically induced endometriosis, mast cell degranulation, peripheral sensitization, endometriotic cysts, nerve growth factor, cyclooxygenase-2, vascular endothelial growth factor, TRPV1, dorsal root ganglia, histamine, TNF-α

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mast cell stabilizer ketotifen reduces hyperalgesia in a rodent model of surgically induced endometriosis. https://app.cochat.ai/papers/10.2147/jpr.s195909
The paper
Zhu, T.-H., Zou, G., Ding, S.-J., Li, T.-T., Zhu, L.-B., Wang, J.-Z., Yao, Y.-X., & Zhang, X.-M. (2019). Mast cell stabilizer ketotifen reduces hyperalgesia in a rodent model of surgically induced endometriosis. Journal of Pain Research. https://doi.org/10.2147/jpr.s195909

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.